Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Security class unavailable · CUSIP: 88032L605
Event date: 2024-08-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 359,848
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000078
- Form type
- SC 13G
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Aug 14, 2024
- Reporting period
- Aug 08, 2024
- Description
- Schedule 13G beneficial ownership